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Summary
Introduction: Obstructive sleep apnea syndrome (OSAS) may be suspected at interview, notably
in case of snoring. Various studies suggested a link between primary open angle glaucoma (POAG)
and OSAS. The present study sought to determine OSAS prevalence in POAG associated with
snoring.
Material and methods: Thirty-one snoring glaucomatous patients prospectively underwent
simpliﬁed polysomnography. Ophthalmologic examination ruled out secondary glaucoma and
assessed the glaucomatous neuropathy.
Results: 49% of the patients included were diagnosed with OSAS. Ophthalmologically, glaucoma
showed no speciﬁc characteristics.
Conclusion: Given the high-prevalence of OSAS in patients with POAG, presence of snoring
should be explored at interview. Conversely, patients who snore should be asked whether they
have POAG, and if so, should undergo all-night sleep recording to explore for OSAS.
© 2010 Elsevier Masson SAS. All rights reserved.
‘IntroductionSnoring consists in pharyngeal tissue vibration during sleep.
It is due to a slight narrowing of the upper airway and
accelerated airﬂow. When isolated, it is referred to as
 The topic of the present article was in part presented at
the French Society of Research and Sleep Medicine (SFRMS) 2008
Congress.
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doi:10.1016/j.anorl.2010.07.003‘simple’’. Pharyngeal narrowing may in some cases be more
evere, signiﬁcantly reducing airﬂow and causing hypopnea
r apnea, in which case the snoring comes under obstructive
leep apnea syndrome (OSAS).
In the early years of snoring treatment, ENT physicians
ere not required to investigate and diagnose OSAS objec-
ively and systematically; the interview alone allowed OSAS
o be ruled out, via a few questions to establish absence
f daytime somnolence or the observation of a young non-
bese patient. In 2006, the French ORL Society’s report
ndicated that, in isolated snoring without associated car-
iovascular risk factors and with no demand for treatment,
served.
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ll-night sleep recording was not justiﬁed [1]; this makes the
nterview the determining element to rule out OSAS.
To optimize screening, the interview is thus a key ele-
ent, and should include relevant items. The patient or
elatives are usually asked about visible nighttime apnea or
aytime somnolence (preferably assessed on the Epworth
omnolence scale).
Certain pathologies, such as elevated arterial pressure,
re found in relatively close association with OSAS. In the
peciﬁc context of OSAS, high blood pressure is often treat-
ent resistant [2]. The presence of such pathologies may
nd should be taken as suggesting OSAS.
In recent years, there have been some 20 reports of asso-
iations between OSAS and certain ophthalmic pathologies,
otably including ﬂoppy eyelid syndrome [3], acute ischemic
ptic neuropathy [4] and open-angle glaucoma [5—18].
Open-angle glaucoma is a chronic optic nerve pathology
nvolving retinal ﬁber degeneration, potentially inducing
lindness in the long term if not treated. Optic disc abnor-
alities are often, but not systematically associated with
levated intraocular pressure (normal tension glaucoma
NTG]), and visual ﬁeld modiﬁcations. The main treatment
onsists in lowering intraocular pressure, but cardiovas-
ular risk factors are also systematically investigated and
reated as required, in the hope of slowing down evolu-
ion. The principal risk factors are hypotension, systemic
rterial hypertension, diabetes, hypercholesterolemia and
therosclerosis stigmata. Recently, OSAS has also begun to
e investigated: certain studies of glaucoma reported a
igher rate of associated OSAS than found in the general
opulation [6—8,19]. It would not, however, be reasonable
o subject all primary open-angle glaucoma (POAG) patients
o all-night recording, and it would therefore be useful to
ake patient interviews more sensitive, by including the
uestion ‘‘Do you snore?’’ in the ophthalmologist’s check-
ist and ‘‘Do you have open-angle glaucoma?’’ in that of the
NT physician.
The present pilot study sought to determine OSAS preva-
ence in a population of glaucoma patients with associated
noring.
aterial and methods
his was an open prospective single-center pilot study with
irect patient beneﬁt, in accordance with the 1983 Helsinki
eclaration.
tudy population
nclusion criteria were presence of primary open-angle
laucoma (POAG), deﬁned by the association of clinically
dentiﬁable glaucomatous optic neuropathy, concordant
erimetric deﬁcit, whether treated or de novo, age greater
han 40 years, and chronic snoring detected on interview
ith the patient and relatives. Other cardiovascular risk
actors were not exclusion factors, if controlled.These inclusion criteria were designed to enhance sensi-
ivity and rule out other cardiovascular risk factors liable to
ggravate the glaucomatous optic neuropathy. Patients pre-
enting with secondary glaucoma (post-traumatic, uveitic,
seudoexfoliative, pigmentary, etc.), closed-angle glau-
T
a
u
n
eE. Blumen Ohana et al.
oma or non-controlled cardiovascular risk factors (systemic
rterial hypertension, diabetes) were excluded.
ethod
atients presenting with POAG, meeting the inclusion crite-
ia and without exclusion factors, were asked to participate.
fter reading the information document and providing
nformed consent, the selected patients went through a
etailed assessment interview, covering terrain, including
ge, gender, time of POAG evolution, ongoing ocular
nd general treatment and associated cardiovascular risk
actors, and also nocturnal respiratory symptomatology
snoring).
Clinical ophthalmological examination comprised mea-
urement of best-corrected visual acuity, several intra-
cular pressure readings with Goldmann applanation
onometry, gonioscopy, central corneal pachymetry, and
ptic disc examination with cup/disc ratio assessment.
Complementary examinations included standard auto-
ated perimetry (Humphrey 24-2, SITA [Swedish Interactive
hreshold Algorithm] standard program), retinal nerve ﬁber
nalysis by GDx-VCC scanning laser polarimetry, and red-free
undus photography.
Sleep apnea was explored by ambulatory type III
olysomnography (nocturnal ventilatory polygraphy). This
xamination assessed snoring, nasobuccal airﬂow, arte-
ial blood oxygen saturation, heart-rate, thoraco-abdominal
ovement and body position. Elements analyzed were:
pnea, hypopnea, minimal and mean blood oxygen satu-
ation, percentage arterial blood oxygen saturation time
elow 90%, snoring time and snoring time according to body
osition (dorsal decubitus or not). Apnea was deﬁned as
ore than 90% reduction in nasobuccal airﬂow, and hypop-
ea as a reduction of more than 50% or of more than 30%
ssociated with at least 3% arterial blood oxygen desatu-
ation. OSAS was deﬁned as an apnea-hypopnea index (AHI)
reater than 10 per hour of analysis. Dorsal OSAS was deﬁned
s AHI > 10 in dorsal decubitus associated with a normal AHI
or the night as a whole. Severe OSAS was deﬁned as AHI > 30
er hour of analysis.
The examinations were performed within 6 months of
nclusion.
tatistics
ata are expressed as mean± standard deviation. Analysis
sed the Mann-Whitney test to compare means and Chi2 to
nalyze proportions. The signiﬁcance threshold was set at
< 0.05.
esults
emographic parametershirty-three patients presenting with POAG reported snoring
t interview and agreed to take part in the study and
ndergo sleep polygraphy. Two polygraphic recordings were
on-interpretable, and the corresponding patients had to be
xcluded as they declined the offer of a second recording.
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Table 1 Ophthalmologic characteristics of the study
population.
Right eye Left eye
VA 0.9 ± 0.2 0.8 ± 0.3
CCT () 534.8 ± 38.9 534.3 ± 37.9
IOP under treatment
(mmHg)
17.7 ± 4.9 17.8 ± 6.0
C/D 0.6 ± 0.2 0.6 ± 0.3
MD −6.3 ± 7.0 −6.4 ± 8.7
PSD 7.8 ± 7.7 7.8 ± 8.4
NFI 47.0 ± 30.6 35.2 ± 25.7
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lVA: visual acuity; CCT: central corneal thickness; IOP: intraocular
pressure; C/D: cup/disc ratio; MD: mean deviation; PSD: pattern
standard deviation; NFI: nerve ﬁber indicator.
Twenty of the 31 patients ﬁnally included were male, 11
female; mean age was 58.1± 9.0 years. Mean body mass
index was 26.5± 4.1 kg/m2. The ethnic distribution was 75%
Caucasian, 19 melanodermic and 6% Hispanic.
Ophthalmologic parameters
Table 1 presents the ophthalmologic parameters. Six
patients presented with NTG, and 25 with POAG. Glaucoma
had been diagnosed 3.1 years (mean) previously.
Cardiorespiratory parameters
Mean snoring time was 26± 16.7% of examination time.
Almost half of the patients (49%) presented with OSAS
(three with NTG, 12 with POAG); ﬁve other patients (16%:
one with NTG, four with POAG) presented with exclusively
dorsal OSAS.
In 60% of OSAS patients, the syndrome was severe.
The two groups of glaucoma patients with and without
OSAS showed no signiﬁcant differences in demographic or
e
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Table 2 Comparison between patient groups with and without O
Without OSAS
Sample (n) 16
Age (years) 57.6 ± 7.9
HTT 1.7 ± 1
RF 1.4 ± 0.8
CCT () 536.3 ± 45.7
IOP (mmHg) 19.2 ± 5.9
MD −8.3 ± 7.6
PSD 7.8 ± 4.8
NFI 50.8 ± 28
AHI (/hr analysis) 4.7 ± 2.7
Desaturation index 4.8 ± 3.7
Mean saturation (%) 95.1 ± 1.7
Minimum saturation (%) 85.6 ± 3.8
% t sat < 90% (%) 1.5 ± 2.6
HTT: number of hypotonic treatments; RF: number of glaucoma risk fa
MD: median deviation; PSD: pattern standard deviation; NFI: nerve ﬁbe
time with arterial blood oxygen saturation less than 90%.161
n ophthalmic characteristics. The two groups of mild and
evere OSAS showed no differences in ophthalmic character-
stics. There were, however, signiﬁcant differences between
he two groups of glaucoma patients with and without OSAS
n cardiorespiratory terms, in AHI (which deﬁned the OSAS
nd non-OSAS groups) and in arterial blood oxygen saturation
desaturation index and mean saturation) (Table 2).
iscussion
he present study assessed sleep apnea syndrome preva-
ence in a population of patients with open-angle glaucoma
ho were aware that they snored at night. OSAS was present
n 49% of cases. This is a high prevalence, compared to 2—4%
n the general population [20].
OSAS is well known to be associated with sys-
emic morbidity, particularly cardiovascular, neurologic and
etabolic.
Associations with various ocular pathologies have also
een reported: ﬂoppy eyelid syndrome [3], corneal modi-
cations (superﬁcial punctuate keratitis, ulceration, scars)
3], and optic neuropathy, including anterior ischemic optic
europathy [4]. For example, the prevalence of OSAS is 89%
n acute anterior optic neuropathy [4].
OSAS has been reported in association with POAG or
TG [5—18]. The literature is unanimous as to the preva-
ence of OSAS in glaucoma, which is higher than in the
eneral population and reaches 44% according to Mojon [19]
Table 3). This unequivocal ﬁnding implies that ophthal-
ologists following and treating glaucoma patients should
eep this association in mind for the purposes of overall
atient management and screening for vascular risk factors
iable to aggravate glaucomatous optic pathology. This could
nable a dialog with physicians assessing glaucoma patients
or general etiological and risk factors: OSAS could be sug-
ested to them, alongside nocturnal arterial hypotension
r a vasospastic terrain, to optimize management of these
ardiovascular risk factors.
SAS.
With OSAS P
15
58.6 ± 10.3 0.904
1.5 ± 1.0 0.446
1.6 ± 1.0 0.888
532.6 ± 29.9 0.758
16.1 ± 3.7 0.790
−4.6 ± 4.0 0.506
8.0 ± 6.2 0.790
35.3 ± 17.7 0.951
31.4 ± 18.9 < 0.0001
23.9 ± 22.1 0.012
92.7 ± 3.6 0.019
79.5 ± 9.4 0.057
33.1 ± 36.7 0.110
ctors; CCT: central corneal thickness; IOP: intraocular pressure;
r indicator; AHI: apnea hypopnea index; % t sat < 90%: percentage
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Table 3 OSAS prevalence in POAG in the literature.
Reference Type of study Number and type of
patients
OSAS prevalence
Other results
Onen et al. [7] Case-Control 212 POAG
218 Controls
Snoring
47.6% (POAG) vs. 38% (Controls)
Snoring + somnolence
27,3% (POAG) vs. 17.8% (Controls)
Snoring + somnolence + insomnia
14.3% (POAG) vs. 7.8% (Controls)
Mojon et al. [6] Transverse
observational
30 POAG +ve oxymetry: 20%
Mojon et al. [19] Transverse
observational
16 NTG 44%
63% when > 64 years of age
Marcus et al. [8] Case control 23 NTG
14 susp NTG
30 controls
Interview indicating SAS: 57%
(NTG), 43% (susp NTG), 3%
(controls)
PSG: 39% (NTG), 28.5% (susp NTG)
NTG
p
c
w
ﬁ
i
w
o
s
N
r
i
t
i
p
h
p
t
e
w
‘
r
p
2
i
t
w
e
g
w
O
c
s
o
i
c
o
o
b
m
p
n
T
a
e
s
w
c
w
s
t
l
p
s
n
w
T
a
s
r
t
p
O
wPOAG: primary open-angle glaucoma; SAS: sleep apnea syndrome;
phy.
Diagnosing POAG, however, may be more difﬁcult in OSAS
atients. There are in fact two types of open-angle glau-
oma: glaucoma with elevated intra-ocular pressure and
ith normal pressure (NTG). Diagnosis of NTG is more dif-
cult, as it is not founded on the observation of elevated
ntra-ocular pressure, which on the contrary is normal. OSAS
ould seem to be a risk factor for NTG [8], probably involving
ther related physiopathological mechanisms. The present
tudy, indeed, highlighted the high prevalence of OSAS in
TG, in agreement with Mojon et al. [19]. Batisse et al.
eported signiﬁcant impairment on blue/yellow perimetry
n OSAS, despite normal intraocular pressure [10].
Additionally, the retinal nerve ﬁber (RNF) layer around
he optic disc was thinner in moderate to severe OSAS than
n a control group of patients [11]: this study suggested a
ossible impact on the ganglion cells even when glaucoma is
ard to demonstrate clinically or on standard computerized
erimetry, on which no abnormalities are observable until
here has been considerable RNF depletion. This may also
xplain why it should be harder to diagnose POAG in patients
ith apnea.
Investigating glaucoma in OSAS populations is less
‘fruitful’’: most studies of POAG prevalence in OSAS
eported elevated rates (Table 4), but with low overall
revalence (2% POAG in the general population vs. 8 to
7% in OSAS populations) [5,13—15,21], sometimes indeed
dentical to that found in a normal population [9,18].
These various prevalence studies raise the question of
he physiopathological relation between POAG and OSAS,
hich remains to be clariﬁed: is there a relation of cause and
ffect? Is there some risk factor common to both patholo-
ies?
Several physiopathologic hypotheses have been put for-
ard to account for the correlation between POAG and
SAS. The tendency is towards a vascular explanation, or
ommon risk factors in the two pathologies. The hypotheses
uggested [22] mainly involve the vascularization of the head
e
c
E
a: normal tension glaucoma; Susp: suspected; PSG: polysomnogra-
f the optic nerve, threatened by repeated apnea inducing
terative desaturation-resaturation, or by variations in vas-
ular blood-ﬂow due to plasma endothelin elevation [23]
r to intermittent sympathetic stimulation [22] impacting
ptic nerve vascular self-regulation. Nocturnal variations in
lood pressure may also be involved [24]. Finally, nycthe-
eral intraocular pressure patterns may be altered in OSAS
atients, inducing a predisposition to glaucomatous optical
europathy in apnea patients, whether treated or not [17].
hese hypotheses remain to be proven.
There is also the issue of OSAS management and the
pparently beneﬁcial impact of OSAS treatment on the
volution of POAG [25]. A recent study of intraocular pres-
ure in apnea found nycthemeral pressure ﬂuctuations,
ith increased intraocular pressure following the start of
ontinuous positive airway pressure therapy and regression
hen ventilation was stopped [17]. Long-term follow-up
tudies will be required to determine the impact of OSAS
reatment on POAG progression, with perhaps strict surveil-
ance of certain patients managed by mechanical continuous
ositive airway pressure.
The present study has two limitations, which readers
hould bear in mind. The ﬁrst is that the focus was certainly
ot on the prevalence of OSAS in a glaucoma population,
hich would doubtless be lower than that reported here.
he frequency of chronic snoring in glaucoma was not
ssessed: the study design deliberately did not include non-
noring glaucoma patients, for both ethical and economic
easons. Non-snorers are unlikely to have OSAS, and a cer-
ain number of patients would have undergone completely
ointless recording. The literature contains one study, by
nen et al., assessing prevalence of snoring in glaucoma,
hich was found to be 47.6% [7], a ﬁgure at the top
nd of the range of snoring prevalence (28 to 44%) in so-
alled ‘‘normal’’ populations, reported by Young et al. [20].
xtrapolating the results of the present study would suggest
round 23% OSAS in glaucoma, versus 3% in normal popula-
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Table 4 PAOG prevalence in SAS in the literature.
Reference Type of study Type of patients PAOG prevalence
Other results
Bendel et al. [14] Observational 100 SAS 27%
No correlation
between POAG and
AHI, age or BMI
Karacukuk et al. [16] Observational 31 SAS 12.9%
Correlation between
AHI and IOP
Mojon et al. [5] Observational 69 SAS 7%
Sergi et al. [15] Case control 51 SAS
40 controls
5.9% (SAS) versus 0%
(Controls)
Correlation between
AHI and IOP
Kadyan et al. [18] Case control 89 severe SAS
26 controls
3.4% (SAS) vs. 3.8%
(Controls)
Geyer et al. [9] Observational 228 SAS 2%
No correlation
between AHI and IOP
41
35
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RTsang et al. [13] Case control
AHI: apnea hypopnea index; SAS: sleep apnea syndrome; IOP: intr
tions; an epidemiological study of snoring and OSAS in POAG
would be required to conﬁrm this extrapolation.
The second study limitation concerns relatives’ reports
of snoring: in the absence of any such witness (family or
friends), the interviewing physician may miss this sign. Cer-
tain patients may have been unaware of their snoring, and
thus failed to be included. It is, however, unusual nowadays
not to sleep in presence of a witness at some time or another.
For all the included patients, there was a witness of snoring.
To the best of our knowledge, there have as yet been
no studies of OSAS prevalence in POAG with associated
nocturnal snoring. This sign, nevertheless, is well worth
investigating, as most patients with obstructive SAS do
snore. It is quite an easy sign to identify, as long as there
are witnesses to the noise the patient makes at night: many
snorers are in fact unaware of or indeed deny making such
noise at night. We consider snoring to be a good inter-
view index for ophthalmologists to guide and optimize OSAS
screening, especially in case of glaucoma. In fact, using the
sole criterion of snoring to screen for OSAS would detect
OSAS at a prevalence of 7% in women and 17% in men in the
general population [20].
Conclusion
The present study found a 49% prevalence of OSAS in POAG
when associated with snoring. It would therefore be relevant
for ENT and ophthalmic physicians to include items on POAG
or snoring respectively in their patient interview.
Further studies will determine whether OSAS is a risk fac-
tor as such for POAG, or rather an aggravating factor due to
the blood pressure variations induced in the systemic vascu-SAS
controls
4 times as many disc
abnormalities in SAS
lar pressure; POAG: primary open-angle glaucoma.
ar circulation. In either case, OSAS screening and treatment
ould certainly prevent severe cardiovascular complications
nd possibly slow down the evolution of POAG.
onﬂict of interest
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